MediCool develops technology for the painless prevention and termination of dangerous cardiac arrhythmias. Our initial focus is in the treatment of atrial fibrillation, the most common arrhythmia, currently affecting over 6 million Americans.
| Website | http://www.medicooltech.com |
| Employees | 7 (5 on RocketReach) |
| Phone | +1 667-367-3080 |
| Technologies |
JavaScript
,
HTML
,
PHP
+6 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Atrial Fibrillation Treatment, Medical Device Technology, Heart Health Solutions, Arrhythmia Management, Cardiac Ablation, Cardiovascular Technology, Heart Rhythm Management, Electrophysiology Devices, Cardiac Monitoring Devices |
| Competitors | Thermo Fisher Scientific, VWR, part of Avantor, GE HealthCare, Pall Corporation, Miltenyi Biotec, BD, Eppendorf Group, PerkinElmer, Inc., Agilent Technologies, Bio-Rad Laboratories +44 more (view full list) |
Looking for a particular MediCool Technologies employee's phone or email?
Jeff Rynbrandt is the President and CEO of MediCool Technologies.
5 people are employed at MediCool Technologies.
MediCool Technologies is based in Traverse City, Michigan.